Photocatalytic degradation of cefotaxime pharmaceutical compounds onto a modified nanocatalyst

Noor. S. Abbood,Nisreen S. Ali,Eman H. Khader,Hasan. Sh. Majdi,Talib M. Albayati,Noori M. Cata Saady
DOI: https://doi.org/10.1007/s11164-022-04879-3
IF: 3.134
2022-11-17
Research on Chemical Intermediates
Abstract:The photocatalytic advanced oxidation process as treatment for the removal of cefotaxime pharmaceutical compounds was conducted onto a modified nanocatalyst. Using photocatalysis with hydrogen peroxide (H 2 O 2 ) in advanced oxidation processes (AOPs) is a suitable and alternative method. Therefore, this study targeted acquiring insights into using ultraviolet (UV) light radiation sources with two types of nanocatalysts (i.e., TiO 2 and TiO 2 /kaolin) to reduce cefotaxime contaminants. The characterization properties of both catalysts were determined using X-ray diffraction (XRD), scanning electron microscopy (SEM), Brunauer–Emmett–Teller (BET), and Fourier-transform infrared spectroscopy (FT-IR). The study investigated the effects of the irradiation time (10–120 min), cefotaxime concentration (10–40 mg/L), TiO 2 dose (0.05–0.2 g), and pH (4–8) on the decomposition cefotaxime. The highest degradation with pure TiO 2 was obtained at a contact time of 90 min, cefotaxime concentration of 10 mg/L, TiO 2 dose of 0.2 g, and a pH of 4, with a removal efficiency of almost 68%. The results indicated that cefotaxime can easily be oxidized with a TiO 2 /kaolin catalyst with a removal efficiency of approximately 99.8% when using a UV/H 2 O 2 treatment. The UV/H 2 O 2 oxidation was more effective and sustainable as well as being a promising technique for the treatment of cefotaxime in wastewater.
chemistry, multidisciplinary
What problem does this paper attempt to address?